About
Nathalie Donis is a researcher affiliated with the Clinical Pharmacology Research Group, specializing in biomarker development for glioblastoma diagnosis and monitoring, anticoagulant pharmacology, and thrombosis risk analysis. Her work intersects biomedical research with clinical applications.
- Role: Researcher and Principal Investigator (PI)
- Key Projects: GLIOMARKERS (glioblastoma biomarkers), AVRI (radiotherapy-induced atherosclerosis)
Her research focuses on:
- Identifying epigenetic modifications in nucleosomes as glioblastoma biomarkers
- Evaluating thrombotic risks of hormonal contraceptives
- Analyzing pharmacodynamic failures in anticoagulant therapies
Recent publications highlight her contributions to:
- Liquid biopsy techniques for tumor monitoring
- Comparative efficacy of natural vs. synthetic estrogens
- Understanding anticoagulant drug failures in atrial fibrillation
Collaborations include supervision by Prof. Jean-Michel Dogné and Prof. Jonathan Douxfils.
0Publications listed
Find Nathalie Donis elsewhere
Related Searches
You Might Also Like
- LLorian RONVAUXUniversity of Namur · Researcher
Jonathan EvrardUniversity of Namur · Researcher- CCeline BouvyUniversity of Namur · Researcher
Marie DidembourgUniversity of Namur · Researcher
Laure MorimontUniversity of Namur · Researcher- PPaulus KirchhofUniversity Medical Center Hamburg-Eppendorf · Professor